ELGX News and Press, Endologix Inc. From 02/25/19

Endologix (NASDAQ: ELGX ): Q4 GAAP EPS of -$0.26 misses by $0.01 . More news on: Endologix Inc, Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

Endologix, Inc. (the “Company”) (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the fourth quarter and fiscal year ended December 31, 2018. Global revenue in the fourth quarter of 2018 was $34...

ALSN , APLE , APTS , ATH , AWR , BWXT , CDEV , CORT , CRZO , DRH , ELGX , EPR , ETSY , FRAC , FRGI , GSM , HNI , HTZ , IMMU , JBT , KAMN , KBR , LSI , MEDP , MOS , NGHC , NLS , OFIX , OKE , PBPB , PEB , PLOW , PODD , QTS , RCII , RP , RRC , SHAK , SNHY...

Endologix, Inc. (Nasdaq: ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of inducement equity awards to eight newly hired employees (the “Awardees”). The awards were approved by the Comp...

NEW YORK, Feb. 07, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Micron Technology, Inc. (NASDAQ:MU), Endologix, Inc. (NASDAQ:ELGX), Group 1 Au...

Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the fourth quarter and fiscal year 2018 after the market close on Monday, February 25, 2019. The Company’s management ...

Endologix® Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the EC Certificate of Conformity (CE Mark) for the Nellix EndoVascular Aneurysm Sealing System (Nellix System) has been suspended by its Notified Body, GMED, foll...

Endologix, Inc. (the “Company”) (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the fourth quarter ended December 31, 2018 is expected to be approximately $34 million. Revenue for ...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Yep, there is an election next week that's going to steal some headlines, but inves...